To study the response of individual muscle fiber types to snake venom PLA2 myotoxins, we have tested the effect of ACLMT (ACL myotoxin fromAgkistrodon contortrix laticinctus) on soleus andgastrocnemius mice muscles. All animals received 5 mg of ACLMT/kg into the subcutaneous lateral region of the right hind limb, near the Achilles tendon. The contralateral muscles were used as control. Frozen muscles were cut at medial region in Cryostat and alternate serial cross-sections stained with Toluidine Blue and for Acid Phosphatase, Myofibrillar ATPase activity, Succinate Dehydrogenase and Acetilcholinesterase. Signs of fiber injury were identified, three hours after ACLMT injection, in both muscles. Three days after, these muscles showed clusters of recovered muscle fibers. Twenty-one days after soleus and gastrocnemius presented only chronic signs of damage as split fibers and centralized nucleus. By m-ATPase reactions was possible to identify that both muscle fiber types I and II were injured in both muscles by ACLMT. Significative increased number of fiber type IIC (17.37 ± 4.11versus 1.0 ± 0.6; p=0.008, paired Student t-test) and decrease of type II (60.7 ± 8.8 versus 76.8 ± 10.1; p=0.01, paired Student t-test), suggest muscle fiber type change from type II to type I through type IIC. Although ACLMT is known by its myotoxic activity, the results presented here showed that it can also be used as model to induce axonal remodeling and muscle fiber type change in both fast and slow muscle fibers of mice.